Detalhe da pesquisa
1.
Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti-TNF-refractory Crohn's disease.
Aliment Pharmacol Ther
; 52(8): 1341-1352, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32955122